Silicon Laboratories (NASDAQ:SLAB) Issues Earnings Results

Silicon Laboratories (NASDAQ:SLAB) announced its quarterly earnings results on Tuesday. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.11), RTT News reports. Silicon Laboratories had a negative return on equity of 12.60% and a negative net margin of 46.93%. The business had revenue of $166.25 million for the quarter, compared to the consensus estimate of $166.09 million. During the same period last year, the business posted ($1.19) EPS. The business’s revenue was up 91.4% compared to the same quarter last year. Silicon Laboratories updated its Q1 2025 guidance to -0.190-0.010 EPS and its Q1 guidance to $(0.19)-0.01 EPS.

Silicon Laboratories Stock Performance

Shares of SLAB stock traded down $1.53 during trading hours on Thursday, hitting $147.53. The company had a trading volume of 132,049 shares, compared to its average volume of 345,061. The firm has a market capitalization of $4.79 billion, a price-to-earnings ratio of -19.93 and a beta of 1.16. Silicon Laboratories has a 12 month low of $94.00 and a 12 month high of $154.91. The firm’s fifty day moving average is $128.35 and its 200 day moving average is $116.74.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on SLAB shares. Needham & Company LLC raised their target price on shares of Silicon Laboratories from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday. KeyCorp upped their price objective on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 22nd. Susquehanna initiated coverage on Silicon Laboratories in a research report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price target on the stock. Barclays boosted their price target on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a report on Friday, January 17th. Finally, Morgan Stanley dropped their target price on shares of Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $136.20.

Insider Transactions at Silicon Laboratories

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the company’s stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the transaction, the director now directly owns 32,115 shares of the company’s stock, valued at $4,520,828.55. This represents a 5.86 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.72% of the stock is owned by company insiders.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.